HOUSE DOCKET, NO. 2600        FILED ON: 2/18/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2103

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Bradley H. Jones, Jr.

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to treatment for substance use disorder.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Bradley H. Jones, Jr.

20th Middlesex

2/8/2021

Susan Williams Gifford

2nd Plymouth

2/25/2021

Angelo L. D'Emilia

8th Plymouth

2/26/2021

Paul K. Frost

7th Worcester

3/11/2021

Hannah Kane

11th Worcester

3/18/2021

Kimberly N. Ferguson

1st Worcester

3/22/2021

Mathew J. Muratore

1st Plymouth

3/25/2021

Steven S. Howitt

4th Bristol

3/31/2021


HOUSE DOCKET, NO. 2600        FILED ON: 2/18/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2103

By Mr. Jones of North Reading, a petition (accompanied by bill, House, No. 2103) of Bradley H. Jones, Jr. and others relative to treatment for substance use disorder.  Mental Health, Substance Use and Recovery.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Second General Court
(2021-2022)

_______________

 

An Act relative to treatment for substance use disorder.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Section 51 ½ of Chapter 111 of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by striking subsection (d) in its entirety and inserting the following thereof:-

(d) If a person has received a substance abuse evaluation and returns to an acute care hospital or emergency satellite facility within seven days of receipt of such evaluation suffering from an opiate-related overdose or has recently been administered naloxone, the attending physician may authorize the restraint of such person and apply for the treatment of such person for a 3-day period at a facility authorized for such purposes by the department of public health or the department of mental health.